vs
Side-by-side financial comparison of Danaher Corporation (DHR) and GE HealthCare (GEHC). Click either name above to swap in a different company.
Danaher Corporation is the larger business by last-quarter revenue ($6.0B vs $5.7B, roughly 1.0× GE HealthCare). Danaher Corporation runs the higher net margin — 17.3% vs 10.3%, a 7.0% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.1% vs 3.7%). Over the past eight quarters, GE HealthCare's revenue compounded faster (10.7% CAGR vs 1.8%).
Danaher CorporationDHREarnings & Financial Report
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments,...
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
DHR vs GEHC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.0B | $5.7B |
| Net Profit | $1.0B | $588.0M |
| Gross Margin | 60.3% | 39.7% |
| Operating Margin | 22.6% | 14.5% |
| Net Margin | 17.3% | 10.3% |
| Revenue YoY | 3.7% | 7.1% |
| Net Profit YoY | 7.9% | -18.4% |
| EPS (diluted) | $1.45 | $1.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.8B | $5.7B | ||
| Q3 25 | $6.1B | $5.1B | ||
| Q2 25 | $5.9B | $5.0B | ||
| Q1 25 | $5.7B | $4.8B | ||
| Q4 24 | $6.5B | $5.3B | ||
| Q3 24 | $5.8B | $4.9B | ||
| Q2 24 | $5.7B | $4.8B |
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $588.0M | ||
| Q3 25 | $908.0M | $446.0M | ||
| Q2 25 | $555.0M | $486.0M | ||
| Q1 25 | $954.0M | $564.0M | ||
| Q4 24 | $1.1B | $721.0M | ||
| Q3 24 | $818.0M | $470.0M | ||
| Q2 24 | $907.0M | $428.0M |
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | 39.7% | ||
| Q3 25 | 58.2% | 38.7% | ||
| Q2 25 | 59.3% | 39.6% | ||
| Q1 25 | 61.2% | 42.1% | ||
| Q4 24 | 59.5% | 42.8% | ||
| Q3 24 | 58.7% | 41.7% | ||
| Q2 24 | 59.7% | 41.4% |
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | 14.5% | ||
| Q3 25 | 19.1% | 12.7% | ||
| Q2 25 | 12.8% | 13.1% | ||
| Q1 25 | 22.2% | 13.2% | ||
| Q4 24 | 21.8% | 15.1% | ||
| Q3 24 | 16.5% | 13.9% | ||
| Q2 24 | 20.3% | 12.6% |
| Q1 26 | 17.3% | — | ||
| Q4 25 | 17.5% | 10.3% | ||
| Q3 25 | 15.0% | 8.7% | ||
| Q2 25 | 9.3% | 9.7% | ||
| Q1 25 | 16.6% | 11.8% | ||
| Q4 24 | 16.6% | 13.6% | ||
| Q3 24 | 14.1% | 9.7% | ||
| Q2 24 | 15.8% | 8.8% |
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | $1.28 | ||
| Q3 25 | $1.27 | $0.98 | ||
| Q2 25 | $0.77 | $1.06 | ||
| Q1 25 | $1.32 | $1.23 | ||
| Q4 24 | $1.50 | $1.58 | ||
| Q3 24 | $1.12 | $1.02 | ||
| Q2 24 | $1.22 | $0.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5B |
| Total DebtLower is stronger | — | $10.0B |
| Stockholders' EquityBook value | — | $10.4B |
| Total Assets | — | $36.9B |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $4.5B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $3.7B | ||
| Q1 25 | — | $2.5B | ||
| Q4 24 | — | $2.9B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | $10.0B | ||
| Q3 25 | $16.9B | $10.3B | ||
| Q2 25 | $17.4B | $10.3B | ||
| Q1 25 | $16.5B | $8.8B | ||
| Q4 24 | $16.0B | $9.0B | ||
| Q3 24 | $17.5B | $10.3B | ||
| Q2 24 | $17.0B | $9.2B |
| Q1 26 | — | — | ||
| Q4 25 | $52.5B | $10.4B | ||
| Q3 25 | $51.1B | $10.0B | ||
| Q2 25 | $52.3B | $9.7B | ||
| Q1 25 | $50.8B | $9.2B | ||
| Q4 24 | $49.5B | $8.4B | ||
| Q3 24 | $51.3B | $8.3B | ||
| Q2 24 | $49.9B | $7.8B |
| Q1 26 | — | — | ||
| Q4 25 | $83.5B | $36.9B | ||
| Q3 25 | $79.9B | $36.1B | ||
| Q2 25 | $81.6B | $35.5B | ||
| Q1 25 | $79.1B | $33.6B | ||
| Q4 24 | $77.5B | $33.1B | ||
| Q3 24 | $80.6B | $33.9B | ||
| Q2 24 | $78.6B | $31.9B |
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 0.96× | ||
| Q3 25 | 0.33× | 1.03× | ||
| Q2 25 | 0.33× | 1.06× | ||
| Q1 25 | 0.32× | 0.95× | ||
| Q4 24 | 0.32× | 1.06× | ||
| Q3 24 | 0.34× | 1.24× | ||
| Q2 24 | 0.34× | 1.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3B | — |
| Free Cash FlowOCF − Capex | $1.1B | — |
| FCF MarginFCF / Revenue | 18.2% | — |
| Capex IntensityCapex / Revenue | 4.0% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.3B | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.3B | $94.0M | ||
| Q1 25 | $1.3B | $250.0M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | $-119.0M |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.1B | $8.0M | ||
| Q1 25 | $1.1B | $98.0M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | $-183.0M |
| Q1 26 | 18.2% | — | ||
| Q4 25 | 25.5% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | 18.4% | 0.2% | ||
| Q1 25 | 18.4% | 2.1% | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 21.0% | — | ||
| Q2 24 | 19.7% | -3.8% |
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | 2.4% | ||
| Q3 25 | 4.8% | 2.1% | ||
| Q2 25 | 4.2% | 1.7% | ||
| Q1 25 | 4.3% | 3.2% | ||
| Q4 24 | 7.9% | 1.9% | ||
| Q3 24 | 5.1% | 1.9% | ||
| Q2 24 | 5.0% | 1.3% |
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 1.83× | — | ||
| Q2 25 | 2.41× | 0.19× | ||
| Q1 25 | 1.36× | 0.44× | ||
| Q4 24 | 1.86× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.56× | -0.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DHR
Segment breakdown not available.
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
